STATIN-FIBRATE REPORT: Focus on Safety

Secondary Prevention. A sub study of the Helsinki Heart Study was conducted in males excluded from the primary prevention cohort due to a history of myocardial infarction, angina or prior ECG changes. There were 628 subjects enrolled in the secondary prevention component of the study who received either gemfibrozil or placebo for 5 years. ................
................

In order to avoid copyright disputes, this page is only a partial summary.